Skip to Main Content

Paper Details

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Cell
348
2020
RBD, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike receptor, epitopes, human, mice
Author NameAffiliation
Alexandra C WallsUniversity of Washington
Brooke FialaUniversity of Washington, USA Institute for Protein Design
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Michael MurphyUniversity of Washington, USA Institute for Protein Design
Mary Jane NavarroUniversity of Washington
John C KraftUniversity of Washington, USA Institute for Protein Design
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Sarah R LeistUniversity of North Carolina at Chapel Hill
Miklos GuttmanUniversity of Washington
Kelly K LeeUniversity of Washington
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Lauren CarterUniversity of Washington, USA Institute for Protein Design
David VeeslerUniversity of Washington
Neil P KingUniversity of Washington, USA Institute for Protein Design
  • 1 - 16

Datasets